Millennium Management’s Syneron Medical Ltd ELOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-742,403
Closed -$7.83M 4150
2017
Q1
$7.83M Buy
742,403
+384,880
+108% +$3.72M 0.01% 1172
2016
Q4
$3M Buy
357,523
+4,148
+1% +$32.5K 0.01% 1650
2016
Q3
$2.53M Buy
353,375
+59,763
+20% +$416K ﹤0.01% 1800
2016
Q2
$2.26M Sell
293,612
-4,580
-2% -$32.6K 0.01% 1723
2016
Q1
$2.18M Sell
298,192
-388,829
-57% -$2.79M 0.01% 1721
2015
Q4
$5.3M Sell
687,021
-81,052
-11% -$618K 0.01% 1321
2015
Q3
$5.49M Sell
768,073
-29,358
-4% -$282K 0.01% 1281
2015
Q2
$8.47M Buy
797,431
+36,282
+5% +$425K 0.02% 1080
2015
Q1
$9.42M Buy
761,149
+531,241
+231% +$5.88M 0.02% 1046
2014
Q4
$2.15M Buy
229,908
+94,130
+69% +$908K ﹤0.01% 1925
2014
Q3
$1.36M Sell
135,778
-8,348
-6% -$84.9K ﹤0.01% 2105
2014
Q2
$1.49M Sell
144,126
-53,912
-27% -$583K ﹤0.01% 1961
2014
Q1
$2.47M Sell
198,038
-43,134
-18% -$511K 0.01% 1630
2013
Q4
$2.97M Sell
241,172
-34,875
-13% -$362K 0.01% 1536
2013
Q3
$2.38M Sell
276,047
-2,623
-0.9% -$22.6K 0.01% 1574
2013
Q2
$2.42M Buy
+278,670
New +$2.49M 0.01% 1470

Other funds holding ELOS

Millennium Management's ELOS Position: Q2 2017 in Review

Millennium Management sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 742,403 shares — an estimated $7.83M sold.

Millennium Management first reported a position in ELOS in Q2 2013 and held it in 16 quarters. The position peaked at $9.42M in Q1 2015. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

  • Millennium Management reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
  • Millennium Management sold 742,403 Syneron Medical Ltd shares in Q2 2017, an estimated $7.83M.
  • Millennium Management first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 16 quarters.
  • Millennium Management's Syneron Medical Ltd position peaked at $9.42M in Q1 2015.
  • 79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on Millennium Management's 13F filing for Q2 2017, filed 14 Aug 2017.